Profound thrombocytopenia after primary exposure to eptifibatide
Nicholas B Norgard, Brian T BadgleyUniversity at Buffalo, School of Pharmacy and Pharmaceutical Sciences, Buffalo, NY, USAAbstract: Eptifibatide is a glycoprotein IIb/IIIa receptor antagonist used to reduce the incidence of ischemic events in patients with acute coronary syndromes and those undergoi...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2010-09-01
|
| Series: | Drug, Healthcare and Patient Safety |
| Online Access: | http://www.dovepress.com/profound-thrombocytopenia-after-primary-exposure-to-eptifibatide-a5329 |